Reuters logo
Pfizer income beats estimates, stands by full-year outlook
July 30, 2013 / 8:16 AM / 4 years ago

Pfizer income beats estimates, stands by full-year outlook

July 30 (Reuters) - Pfizer Inc, the largest U.S. drugmaker, reported second-quarter adjusted income slightly ahead of analysts’ estimates and reaffirmed its financial outlook for the year.

For the second quarter, Pfizer’s adjusted income fell 10 percent to $4.00 billion, or 56 cents a share, from $4.45 billion, or 59 cents a share, a year earlier.

Revenue fell 7 percent to $12.97 billion.

Analysts, on average, were expecting second-quarter income of 55 cents a share, on revenue of $13.01 billion, according to Thomson Reuters I/B/E/S.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below